Market Overview

Benzinga's Top Upgrades

Share:
Benzinga's Top Upgrades

Analysts at Wunderlich upgraded Renasant (NASDAQ: RNST) from “hold” to “buy.” The target price for Renasant has been raised from $20 to $25. Renasant's stock closed at $18.96 yesterday.

Credit Suisse upgraded Discover Financial Services (NYSE: DFS) from “neutral” to “outperform.” The target price for Discover has been raised from $44 to $47. Discover's shares closed at $39.35 yesterday.

Analysts at UBS upgraded Westlake Chemical (NYSE: WLK) from “sell” to “neutral.” The target price for Westlake Chemical has been raised from $66 to $90. Westlake Chemical's shares closed at $91.20 yesterday.

Nomura upgraded MetroPCS Communications (NYSE: PCS) from “reduce” to “neutral.” The target price for MetroPCS is set to $9.50. MetroPCS's shares closed at $9.78 yesterday.

Latest Ratings for RNST

DateFirmActionFromTo
Aug 2019MaintainsHold
Aug 2019Initiates Coverage OnNeutral
Jun 2019Initiates Coverage OnHold

View More Analyst Ratings for RNST
View the Latest Analyst Ratings

Posted-In: top upgradesUpgrades Analyst Ratings

 

Related Articles (DFS + PCS)

View Comments and Join the Discussion!

Latest Ratings

StockFirmActionPT
PTONBank of AmericaInitiates Coverage On29.0
ITRICanaccord GenuityMaintains87.0
GWPHNeedhamInitiates Coverage On200.0
BABairdDowngrades
LUVStifelDowngrades60.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Trading Daily
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com

UPDATE: Laboratory Corp Posts Lower Q4 Profit

Oncolytics Biotech Announces Additional Positive Phase 2 REOLSYIN Clinical Trial Data